Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer

doi:10.4251/wjgo.v14.i3.690

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4133)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-2) series.

Item

Count

PDF

268

WORD

172

HTML

2017

Figures (1-5)

262

Tables (1-2)

236

Sum=2955

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

283

Download

895

Sum=1178

Mar 15, 2022 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastrointest Oncol. Mar 15, 2022; 14(3): 690-702
Published online Mar 15, 2022. doi: 10.4251/wjgo.v14.i3.690

Full Size Figure Download Figure

Figure 3 The gastric cancer subtypes. Epstein-Barr virus enrichment is associated with tumors in the gastric cardia and fundus. Helicobacter pylori enrichment associated with tumors in the pylorus and antrum. Tumors with elevated genomic instability can be observed in any location. CIN: Chromosomal instability; H. pylori: Helicobacter pylori; EBV: Epstein-Barr virus.

Citation: Ye LP, Mao XL, Zhou XB, Wang Y, Xu SW, He SQ, Qian ZL, Zhang XG, Zhai LJ, Peng JB, Gu BB, Jin XX, Song YQ, Li SW. Cost-effective low-coverage whole-genome sequencing assay for the risk stratification of gastric cancer. World J Gastrointest Oncol 2022; 14(3): 690-702
URL: https://www.wjgnet.com/1948-5204/full/v14/i3/690.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i3.690